Blockchain Registration Transaction Record

Immunic Inc Chief Medical Officer Discusses Promising Treatments for IBD on World IBD Day

Dr. Andreas Muehler, Chief Medical Officer of Immunic Inc, discusses promising treatments for Inflammatory Bowel Disease (IBD) on World IBD Day, highlighting new drugs that do not suppress the immune system and offer hope for improved management and potential remission.

Inflammatory Bowel Disease affects a significant portion of the population and can have a major impact on daily life. The discussion of promising treatments, including new drugs that do not suppress the immune system, provides hope for improved management and potential remission for IBD patients. This news highlights the ongoing efforts of Immunic Inc. to develop innovative therapies for IBD, offering potential solutions for those affected by the condition.